Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Chronic Heart Failure
Interventions
DRUG

conivaptan

IV

DRUG

placebo

IV

Trial Locations (26)

10032

New York Presbyterian Hosp, Milstein Hosp., New York

17033

Hershey Medical Center, Hershey

20201

University of Maryland Hospital, Baltimore

29425

Medical University of South Carolina, Charleston

32216

Jacksonville Center for Clinical Research, Jacksonville

33136

U. Miami, Jackson Mem'l Medical Center, Miami

33308

The Greater Fort Lauderdale Heart Group Research, Fort Lauderdale

34478

Discovery Medical Research Group, Ocala

35801

The Heart Center, P.C., Huntsville

38120

Baptist Clinical Research, Memphis

43210

Ohio State University Medical Center, Heart and Lung Research Institute, Columbus

44195

The Cleveland Clinic Foundation, Cleveland

45267

University of Cincinnati, College of Medicine, Div. of Cardiology, Cincinnati

55415

Hennepin County Medical Center, Minneapolis

60612

Rush-Presbyterian St. Luke's Medical Center, Chicago

63110

Washington University, St Louis

70112

Louisiana State University Medical Center School of Medicine, New Orleans

70119

New Orleans Center for Clinical Research, New Orleans

71103

Cardiac Centers of Louisiana, LLC, Shreveport

75231

Cardiovascular Research Institute of Dallas, Dallas

77030

Baylor College of Medicine, Houston

90033

LA County/USC Medical Center, Los Angeles

92705

Apex Research Institute, Santa Ana

95337

San Joaquin Cardiology, Manteca

98195

University of Washington, Seattle

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY